Abstract
Background
To demonstrate the efficacy of positron emission tomography (PET) for examining multiple sclerosis (MS) patients with hemianopia.
Case
A 20-year-old man visited us with a complaint of left homonymous hemianopia and headache.
Observations
The patient’s visual acuity was 1.2 (n.c.) OD and 0.9 (1.0) OS. Magnetic resonance imaging (MRI) showed a mass in the temporoparietal lobe. A pathological diagnosis of MS was made by brain biopsy. Low glucose metabolism in the lesion and visual cortex was observed by PET with 18F-fluorodeoxy glucose. PET with 11C-flumazenyl revealed a reduction of 11C-uptake in the demyelinated optic radiation, and only a slight reduction of 11C-uptake in the primary visual cortex. The results of 11C-flumazenyl PET suggested a slight reduction of neuronal density. In 2 years, the visual field recovered to the normal state.
Conclusion
PET can be a useful tool for estimating the visual outcome of patients with hemianopia in MS. Jpn J Ophthalmol 2004;48:591–593 © Japanese Ophthalmological Society 2004
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Murai, H., Kiyosawa, M., Suzuki, Y. et al. A Case of Multiple Sclerosis with Homonymous Hemianopia Examined by Positron Emission Tomography. Jpn J Ophthalmol 48, 591–593 (2004). https://doi.org/10.1007/s10384-004-0128-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10384-004-0128-1